Recent Finacing
Recent Raise
Regado Biosciences develops injectable antithrombotic aptamers paired with active control agents, advancing clinical candidates REG1 and REG3 for PCI, TAVI, and diabetic vasculopathy.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
